Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
With the increase in prevalence of prostate cancer following the introduction of PSA screening, most cancers are now detected at an early stage. In patients with 'good-risk' prostate cancer there is a risk of overtreatment, but it is important that this should be balanced with the possibility of undertreating those at risk of disease progression.